Lipoprotein(a) (Lp(a))

The unit problem trips up almost everyone who tries to compare two reports. Lp(a) is reported either in mg/dL, which weighs the particle's mass, or in nmol/L, which counts particles. Those are not the same measurement, and Lp(a) particles vary in size from person to person, so there is no honest fixed multiplier between the two. The CDC's framing makes the point: a high cutoff lands near "greater than 50 mg/dL, or greater than 100 nmol/L," two numbers that describe roughly the same risk while looking nothing alike. Compare each result to the unit and range on its own report, never one report's number against another's.

A high Lp(a) is the result this test exists to find, and it almost always traces back to one thing.

• Genetics, first and mostly. The level is largely set by the gene you inherited, which is why a high result tends to run in families and tends to stay put across your life.
• Sex and age can nudge it. The reported level can vary somewhat with sex and shift gradually with age, though these effects are small next to inheritance.
• Other states can move it temporarily. Pregnancy, kidney changes, inflammation, and certain hormone therapies can shift a reading, which is one reason a draw taken during pregnancy or a serious illness is sometimes repeated later.

What a high number does not usually mean is anything you ate, skipped, or failed to do, which surprises people used to lipids responding to effort. A high Lp(a) is a fixed feature of how your liver builds these particles, and the AHA is direct that lifestyle changes do not lower it. The value of finding out is that the number reframes everything else: someone with high Lp(a) and an otherwise unremarkable lipid panel carries more cardiovascular risk than the panel alone suggests, which can change how aggressively a doctor treats the risk factors that do move.

A low Lp(a) is generally good news and, like a high one, is mostly inherited. Some people simply make less of the particle, and that pattern clusters in families for the same genetic reason high levels do. A low result does not say anything about your other lipids or your overall heart health on its own; it is one favorable card in a hand that still includes LDL, blood pressure, blood sugar, and everything else. It also is not a number worth retesting to watch, because there is very little for it to do but stay low.

Lp(a) is read alongside the rest of the cardiac panel, but it answers a question the standard lipids cannot. Total cholesterol, HDL, and triglycerides describe how much cholesterol is moving and in which direction, and the guide to reading a lipid panel walks through how they fit together. Lp(a) describes a fixed, inherited particle those numbers never count, which is why two people with identical-looking panels can carry very different long-term risk.

The closest relative is the particle-counting side of cholesterol testing. Where LDL cholesterol weighs the cargo and apolipoprotein B counts the carriers, Lp(a) is its own distinct particle that neither fully captures; the LDL versus apoB comparison lays out how mass and count can disagree, the same tension that makes Lp(a)'s two units so confusing. Unlike a separately inherited risk lipid, Lp-PLA2 travels bound to LDL, so it tells you less independently than its own number suggests.

Most numbers on a blood test reward being tracked over time, since the trend usually says more than any single point. Lp(a) is the exception. It barely changes, so one good measurement tends to be all the card ever asks of you, provided you read it against the right unit, since the gap between mg/dL and nmol/L can land the same blood in different risk categories. One reading, understood in its own units, is enough.